KWR:NYSEQuaker Houghton analysis
Data as of Oct 11, 2026 - not real-time
- Latest price
- $155.95
- Risk: medium
- 7/10Medium risk
Summary
The moving-average structure behind Quaker Chemical Corporation is neutral at $155.95, with no clear ordering between short and long averages. Across the trailing 30 sessions it lost 5.1%. RSI sits at 43.1, which reads as neutral, and MACD momentum is bearish. Recent trading has carved out support near $151.96 and resistance around $163.79.
On valuation the read is fair — an earnings multiple of 27.8, absent a reliable peer benchmark. The average analyst target implies 23.5% above today's level. Revenue is growing at 10.2% on a 4.9% profit margin. The 1.34% dividend yield looks covered by current payout levels.
Risk scores 7 out of 10, which is elevated for this asset class. With 30-day volatility of 22.1%, a beta of 1.30 and a maximum drawdown of 36.5%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
This one splits by horizon — hold in the near term, buy further out, at 5/10 long-term conviction.
On valuation the read is fair — an earnings multiple of 27.8, absent a reliable peer benchmark. The average analyst target implies 23.5% above today's level. Revenue is growing at 10.2% on a 4.9% profit margin. The 1.34% dividend yield looks covered by current payout levels.
Risk scores 7 out of 10, which is elevated for this asset class. With 30-day volatility of 22.1%, a beta of 1.30 and a maximum drawdown of 36.5%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
This one splits by horizon — hold in the near term, buy further out, at 5/10 long-term conviction.
Top market events
- Quaker Chemical Corporation recently reported that for the second quarter of 2026, sales were US$532.
- Record EBITDA and 28% EPS growth despite margin pressure from raw material costs.
- KWR posted higher Q2 earnings and record adjusted EBITDA as new business wins lifted volumes and revenue, while...
Market outlook
Short term
< 1 yearNeutral
Model confidence3/103 out of 10
Key factors
- Trading above the 200-day average of 149.41
- MACD momentum is negative
- 30-day price change of -5.1%
Medium term
1–3 yearsNeutral
Model confidence4/104 out of 10
Key factors
- Trading above the 200-day average of 149.41
- Analyst targets imply +23.5% versus the current price
- MACD momentum is negative
Long term
> 3 yearsPositive
Model confidence5/105 out of 10
Key factors
- Analyst targets imply +23.5% versus the current price
- Revenue growth of +10.2%
- P/E ratio of 27.8
Key metrics
Financial health
Revenue Growth10.20%
Profit Margin4.95%
P/E Ratio27.8
ROE7.17%
ROA4.10%
Debt/Equity66.91
P/B Ratio1.9
Op. Cash Flow$131.2M
Free Cash Flow$129.9M
Technical analysis
TrendNeutral
RSI43.1
Support$151.96
Resistance$163.79
MA 20$157.89
MA 50$162.26
MA 200$149.41
MACDBearish
VolumeStable
Fear & Greed Index94.93
Valuation
Fair Value$93.21
Target Price$192.57
Upside/Downside23.48%
GradeFair
TypeBlend
Dividend Yield1.34%
Risk assessment
Beta1.30
Volatility22.14%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.